Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more
The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared. read more
Patient-Centric Drug Delivery
Across modalities and markets, patient-centric drug delivery is converging on three themes: self-administration at home, integration of drug delivery device platforms earlier in clinical trials, and alignment of formulations with device and human factors requirements. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Genezen, Galibra Partner on SSADH Gene Therapy
Thursday, October 15, 2026
Genezen and Galibra Neuroscience have entered a manufacturing partnership to prepare Galibra’s experimental gene therapy for succinic semialdehyde ... read more
Charles River, Magellan Partner on Zelestrocel Testing
Thursday, October 15, 2026
Charles River Laboratories has agreed to provide testing and development services to Magellan Stem Cells as the Australian biotechnology company ... read more
Perceptive, Nucleus Form Radiopharmaceutical Partnership
Thursday, October 15, 2026
Perceptive Discovery and Nucleus RadioPharma have formed a nonexclusive partnership linking preclinical testing with clinical manufacturing for ... read more
Lonza Expands Six-Month Biologics Development Offering
Thursday, October 15, 2026
Lonza has expanded its development and manufacturing offering to include more complex biologic medicines, with a stated goal of preparing some ... read more
Lonza Licenses Qurient Technology for Dual-Payload ADCs
Tuesday, October 13, 2026
Lonza has signed an exclusive license agreement with Qurient to use the Korean biotechnology company’s cyclin-dependent kinase 7 inhibitors in dual-... read more